Site Search

You searched for "hepatitis D"

• A Quick Introduction to Public Health Funding in the United States

  Written by Frank Hood- Associate Director of Policy and Partnerships at Hepatitis B Foundation!   The COVID-19 pandemic put a spotlight on why countries need a robustly funded public health system that can respond to the needs of its citizens quickly. In the United States, that public health system is a patchwork of federal, state, and local departments, agencies, and programs. Each has their own rules and regulations, which can be challenging to navigate. You might have a hard time seeing how it all works together without falling apart. And you might struggle to understand how resources can find their way to the local health centers and community-based organizations doing much of the important health work on the ground. This blog post provides a basic overview of how public health funding works within the United States.  Hundreds of federal departments, agencies, and programs funnel money into the public health system of the United States. One of the more familiar organizations is the Department of Health and Human Services (HHS). Among its many health-related functions, HHS handles disease prevention and outbreak response through the Centers for Disease Control and Prevention (CDC) and provides health coverage for underserved and older Americans through the Centers for Medicare and Medicaid Services (CMS). Other departments like the Department of Agriculture (USDA) may not seem like a key source of health funding, and yet support dietary health initiatives and help states build rural medical facilities through infrastructure investment programs. The amount of funding these departments, agencies, and programs receive varies yearly. Some funding, like for Medicare and Medicaid, doesn’t require an annual vote from Congress (known as “mandatory spending” in policy-speak) and is just paid for as expenses are incurred. Other funding, like for the Health Resources and Services Administration (HRSA), requires a yearly vote of Congress as well as sign-off by

  http://www.hepb.org/blog/quick-introduction-public-health-funding-united-states/
• The Making of A State Viral Hepatitis Elimination Plan - The Budget

  In Pennsylvania, the Hepatitis B Foundation is collaborating with various stakeholders to launch a State Viral Hepatitis Elimination Plan! Join us as we document our process from start to finish! This month's installment focuses on speaking with state legislators to ask for funding to support elimination.

  http://www.hepb.org/blog/making-state-viral-hepatitis-elimination-plan-budget/
• Behind the Scenes of A Viral Hepatitis Elimination Plan in Pennsylvania

  In Pennsylvania, the Hepatitis B Foundation is collaborating with various stakeholders to launch a State Viral Hepatitis Elimination Plan! Join us as we document our process from start to finish! In this video, Michaela Jackson, MS recounts the Hepatitis B Foundation's attendance to the first ever State Viral Hepatitis Elimination Stakeholder Planning Meeting! The meeting, which was hosted by the Pennsylvania Department of Health, brought awareness and education to the state's lawmakers!

  http://www.hepb.org/blog/behind-scenes-viral-hepatitis-elimination-plan-pennsylvania/
• Celebrating Hepatitis Awareness Month with a State Hepatitis Elimination Plan

  In Pennsylvania, the Hepatitis B Foundation is collaborating with various stakeholders to launch a State Viral Hepatitis Elimination Plan! Join us as we document our process from start to finish!

  http://www.hepb.org/blog/making-state-viral-hepatitis-elimination-plan/
• Beating the Odds: A Liver Cancer Survivor's Story

  Liver cancer, caused by hepatitis B and C, is on the rise in the U.S. and it is also the second deadliest. Fewer than 15 percent of patients with liver cancer will survive five years after their diagnosis. It is the third-leading cause of cancer deaths among Asian-Americans and the eighth-leading cause of cancer deaths among Caucasian-Americans. Despite this bleak outlook, there are people with liver cancer who are beating the odds and surviving. The medical community is also working hard to develop new drugs and effective strategies to treat liver cancer. Here is one survivor's story. By Frank Gardea Image courtesy of David Castillo Dominici at FreeDigitalPhotos.net In late 2008, during routine testing before surgery, I found out I had hepatitis C and liver cirrhosis. It was a double whammy because having both viral hepatitis and cirrhosis put me at high risk for liver cancer. Then the abdominal pain started. I suffered for almost three years and was in and out of the emergency department. They could not pinpoint the cause of the pain. When they finally diagnosed my liver cancer, the tumor was over 8 cm in size. I was of course angry. Why didn’t they catch my cancer earlier? I was hospitalized for over a week and then referred to the oncology department. That’s when they told me, “You have three months to live.” I was not a candidate for a liver transplant and one of the doctors didn’t even want to give me a referral to a hepatologist because she thought I was too far gone.  I went home and binge-watched YouTube videos on liver cancer. I found out that far too often, by the time liver cancer is diagnosed, it’s too late. Another doctor later referred me to UCLA, one of the top liver cancer centers in the country. At my first appointment at the liver cancer center, I saw Dr. Richard Finn, a leading liver cancer expert, who was part of a team of health care professionals taking care of me. They never once said I was beyond hope. The following week,

  http://www.hepb.org/blog/beating-the-odds-a-liver-cancer-survivors-story/